Primary Care/Hospitalist
RSSArticles
-
COVID-19 Affected U.S. Life Expectancy: How Bad Is It?
The pandemic dinged the average, but the latest data do not tell the whole story.
-
Mindfulness in Disadvantaged Populations
Participation in mindfulness-based group therapy shows promise for reducing stress and improving functioning in this pilot study involving 27 socioeconomically disadvantaged African-American women.
-
Exercise, Screen Time, and Health During the COVID-19 Pandemic
A Canadian survey capturing one week in the early stages of the COVID- 19 pandemic found that respondents reporting exercising outdoors and decreasing or maintaining screen time were more likely to self-report higher levels of mental and physical health. This association was stronger in women when compared to men.
-
Racism, Stress, and Asthma
This cross-sectional study of African-American children 1 to 6 years of age (n = 31) in Kansas City, MO, finds a statistically significant inverse correlation between asthma control (measured by Test for Respiratory and Asthma Control in Kids score) and stress from racism.
-
Pharmacological Therapies in HFrEF: Is Quadruple Therapy a New Standard of Care?
Approximately 50% of patients with heart failure have heart failure with reduced ejection fraction (HFrEF). HFrEF morbidity and mortality are altered favorably with the use of guideline-directed medical therapy. Multiple drug therapies have informed evidence-based therapies for the treatment of HFrEF.
-
Surrogates’ Authority Varies on Mental Health Treatment Decision-Making
Ethicists should be familiar with their respective jurisdictions’ statutes and case law, especially those whose health systems cross state borders.
-
Frail Older Patients Receiving Higher-Intensity End-of-Life Care
There is an opportunity for targeted interventions for all older patients, especially frail older adults, undergoing emergency general surgery to establish better prognostic understanding and discuss advance care planning before hospital discharge.
-
Cabotegravir Extended-Release and Rilpivirine Injectable Suspension (Cabenuva) and Cabotegravir Tablets (Vocabria)
Cabotegravir/rilpivirine (CAB/RPV) should be prescribed to treat HIV-1-infected adults. This combination should replace the current antiretroviral (ARV) regimen in those who are virologically suppressed (HIV-1 RNA < 50 copies/mL) on a stable regimen with no history of treatment failure and no known or suspected resistance to ether CAB or RPV.
-
Subclinical Influenza Infection in Healthcare Workers
Despite all precautions, influenza vaccination, handwashing campaigns, and messaging to staff not to come to work with respiratory symptoms, healthcare workers are an important source of nosocomial influenza and respiratory infection. Now, it is happening with COVID-19.
-
Excess Deaths During COVID-19
Compared with death data for the same weeks from prior years, nearly 300,000 excess deaths occurred in the United States between the weeks ending Jan. 26 through Oct. 3, 2020. Two-thirds were attributed to COVID-19.